BDNF and Huntington disease: Its ability to enhance BDNF, NGF, and GDNF signaling—while mitigating neurodegenerative deficits—positions S1R agonists as promising therapeutics for AD, PD, HD, and other disorders marked by neurotrophic factor depletion.